ConductScience.org, home

Trial · NCT01644643

Results by group866

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcIAI:Best Available TherapyClinical cure627.0 to 80.0Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcIAI:CAZ-AVI + MetronidazoleClinical cure886.3 to 95.4Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcUTI:Best Available TherapyClinical cure12989.3 to 97.2Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcUTI:CAZ-AVIClinical cure132Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcIAI:Best Available TherapyClinical failure0Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcIAI:CAZ-AVI + MetronidazoleClinical failure0Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcUTI:Best Available TherapyClinical failure2Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcUTI:CAZ-AVIClinical failure2Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcIAI:Best Available TherapyIndeterminate5Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcIAI:CAZ-AVI + MetronidazoleIndeterminate2Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcUTI:Best Available TherapyIndeterminate6Participant
Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis SetcUTI:CAZ-AVIIndeterminate10Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cIAI:Best Available TherapyClinical cure6Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cIAI:CAZ-AVI + MetronidazoleClinical cure9Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cUTI:Best Available TherapyClinical cure136Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cUTI:CAZ-AVIClinical cure142Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cIAI:Best Available TherapyClinical failure0Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cIAI:CAZ-AVI + MetronidazoleClinical failure0Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cUTI:Best Available TherapyClinical failure0Participant
Clinical Response at End of Treatment (EOT) in mMITT Analysis Set.cUTI:CAZ-AVIClinical failure0Participant

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01644643/results